Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of Aβ by Metal Ion Stripping and Redox Silencing
Open accessThe DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Abstract
Alzheimer's disease (AD) is the most common neurodegenerative disorder associated with cognitive decline and loss of memory. It is postulated that the generation of reactive oxygen species (ROS) in Fenton-like reaction connected with Cu(II)/Cu(I) redox cycling of the Cu(II)-aβ complex can play a key role in the molecular mechanism of neurotoxicity in AD. Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic regulatory peptide that possesses a high affinity for Cu(II) ions. The ability of the peptide Semax to inhibit the copper-catalyzed oxidation of aβ was studied in vitro and discussed. The results indicate that Semax is able to extract Cu(II) from Cu(II)-aβ species as well as to influence the redox cycling of the Cu(II)-aβ complex and decrease the level of associated ROS production. Finally, our data suggest that Semax shows cytoprotective properties for SH-SY5Y cells against oxidative stress induced by copper-catalyzed oxidation of the aβ peptide. This study provides valuable insights into the potential role of Semax in neurodegenerative disorders and into the design of new compounds with therapeutic potential for AD.
Overview
CoChat Summary
## TL;DR
Semax, a synthetic peptide with high affinity for Cu(II), reduced Cu(II)-catalyzed ROS generation and the resulting cytotoxicity of amyloid-β in vitro and in SH-SY5Y neuroblastoma cells. The paper argues this occurs by stripping Cu(II) from Aβ and “redox silencing” the copper, although some ROS production still remained under conditions where Cu(I) chelators were present.
## Key findings
- In cell-free assays, free Cu(II) caused complete ascorbate consumption and hydroxyl radical production after 30 min, while Aβ reduced both the rate and level of these reactions; Aβ fragments Aβ1–16, Aβ1–28, and Aβ1–40 behaved similarly, with no significant difference reported among them.
- Adding Semax inhibited Cu(II)-mediated ascorbate oxidation and HO• generation, and when Semax:Cu(II) was preformed, adding Aβ did not restore ascorbate consumption or HO• production; the paper reports a conditional dissociation constant of cKd = 1.3 × 10−15 M for Semax:Cu(II).
- In the presence of bicinchoninic acid (BCA), Cu(II) was readily reduced to Cu(I)-(BCA)2; however, if Cu(II)-Semax was already formed, reduction did not occur and no Cu(I)-(BCA)2 was detected after BCA addition.
- In SH-SY5Y cells, Cu(II) + ascorbate and Cu(II) + ascorbate + Aβ increased ROS-positive cells to 68% and 79%, respectively, versus about 10% in untreated cells; Semax reduced these to 41% and 40%. Cell viability dropped to 59% and 63% with Cu(II) + ascorbate and Cu(II) + ascorbate + Aβ, and Semax raised viability to 83% and 82%.
## Methods
- The study combined in vitro spectrophotometric and fluorometric assays with cell-based experiments to test how Semax affects Cu(II)-Aβ redox chemistry and oxidative toxicity.
- Peptides used included Semax, Aβ1–16, Aβ1–28, and Aβ1–40; SH-SY5Y human neuroblastoma cells were used for intracellular ROS detection and MTT viability assays.
- Main analyses included UV monitoring of ascorbate consumption, fluorescence detection of hydroxyl radical formation via 3-CCA/7-OH-CCA, UV-Vis competition experiments with BCA, flow cytometry with H2DCFDA for intracellular ROS, and MTT assay for cell viability; results were analyzed with one-way ANOVA/Tukey or chi-square tests.
## Limitations
- The paper states that Semax did not completely inhibit the Fenton–Haber–Weiss reaction in some conditions; even with Semax, “a small, but significant” consumption of ascorbate and production of OH• persisted.
- The text makes evident that several conclusions are based on in vitro chemistry and a single neuroblastoma cell line, so direct evidence in animal models or patients is not provided in this paper (evident from the reported methods/results).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
1 Valid · 0 Not valid · 3 Not checked · 18 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This behavior, showing that redox inert Cu(II) ATCUN motif is not enough to inhibit ROS production, has been previously shown and explained by other authors [57, 58].”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.2. Semax Inhibits OH• Generation and Ascorbate Consumption Induced by Cu2+ and aβ-Cu2+
What the sources say
- Not checked yetcites [57] source
Checked before — its earlier verdict is held back until a new check runs.
- Supportedcites [58] source
In Results and Discussion §2.1 (page not provided), the paper reports that AAH forms a redox-inert Cu(II) complex but fails to stop Cu(Aβ)-induced ascorbate consumption when added after it begins, because Cu(II) extraction from Aβ is slow. The Concluding Remarks (page not provided) likewise say that an ATCUN complex’s low ROS-forming ability is insufficient on its own: the rate of Cu(II) extraction also matters. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“thus, even if Semax is able to form redox inert Cu(II) complexes and to extract Cu(II) from aβ:Cu(II) complex, the Fenton–Haber–Weiss reaction was not completely inhibited (Figures 2(a) and 2(b), black curves).”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.2. Semax Inhibits OH• Generation and Ascorbate Consumption Induced by Cu2+ and aβ-Cu2+
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the presence of Semax, the copper redox cycling was completely silenced.”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.2. Semax Inhibits OH• Generation and Ascorbate Consumption Induced by Cu2+ and aβ-Cu2+
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The presence of aβ in the ascorbate solution produced a reduction in both the rate and the level of ascorbate consumption after the addition of Cu(II) (Figure 1(a), blue curve) and HO• production (Figure 2(b), blue curve).”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.1. Aβ-Cu2+–Induced ROS
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Exposure to Cu(II) + ascorbate and Cu(II) + ascorbate + aβ reduced the cells' viability to 59% and 63%, respectively, compared to the control.”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.5. Semax Prevents Cu(II)-Ascorbate and Cu(II) Ascorbate-aβ–Induced Cell Death in Cultured Neuroblastoma Cells
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
9 more claims
Create a free account to see all 22 claims and to verify the 1 reference still open.
- It may state two separate claims as one. 7
- Probably not a substantial claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 3. Conclusion
“the presence of the ACTUN motif with a high affinity constant (cKd = 1.3 10–15 M) does not guarantee the complete copper redox silencing if Cu(I) chelator is present in solution.”
§ Semax, a Copper Chelator Peptide, Decreases the Cu(II)-Catalyzed ROS Production and Cytotoxicity of aβ by Metal Ion Stripping and Redox Silencing > 2. Results and Discussion > 2.2. Semax Inhibits OH• Generation and Ascorbate Consumption Induced by Cu2+ and aβ-Cu2+
“Semax is a peptide with ATCUN motif having [CuH−2L]2− as the only very stable complex species able to strongly chelate copper ions at physiological pH and a very negative formal redox potential [71].”
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855 · cited 1×
“Free radicals are generally acknowledged as serious threat for the correct cell functioning [90, 91].”
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Oxyl radicals, redox-sensitive signalling cascades and antioxidants
Genestra, M. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.04.009 · Cited by 4,930
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Neurodegenerative diseases and oxidative stress
Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Oxidative stress and neurodegeneration: where are we now?
Halliwell, B. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03907.x · Cited by 2,614 · cited 1×
“It can convert radicals into nonradicals, for instance HO Transferring an electron to a nonradical species can also result in reactions that lead to the formation of radicals; however, these reactions are normally not efcient [77], unless they are catalyzed [78].”
Oxidative stress and the amyloid beta peptide in Alzheimer’s disease
Cheignon, C., Tomas, M., Bonnefont-Rousselot, D., Faller, P., Hureau, C., & Collin, F. (2018) · Redox Biology · doi:10.1016/j.redox.2017.10.014 · Cited by 2,185 · cited 2×
“A β plays a key role in the metal ion–mediated ROS production during oxidative stress [24, 74–76].”
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120 · cited 1×
“Several studies have shown that the AD-afected brain contains elevated concentrations of transition metals accumulated in amyloid plaques, mainly copper, zinc, and iron, suggesting that these metal ions actively take part in the etiology of the pathology by interacting with a β peptide [3, 9, 12].”
Gaggelli, E., Kozlowski, H., Valensin, D., & Valensin, G. (2006) · Chemical Reviews · doi:10.1021/cr040410w · Cited by 1,729
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
Huang, X., Atwood, C. S., Hartshorn, M. A., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Cuajungco, M. P., Gray, D. N., Lim, J., Moir, R. D., et al. (1999) · Biochemistry · doi:10.1021/bi990438f · Cited by 1,107 · cited 1×
“In vitro studies have shown that, in the presence of copper, a β can produce H 2 O 2 by reducing molecular oxygen [38–40] and catalyzing ascorbate oxidation with the generation of hydroxyl radical ( • OH) through Fenton reaction [41–44].”
Metals, oxidative stress and neurodegenerative disorders
Jomova, K., Vondrakova, D., Lawson, M., & Valko, M. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0563-x · Cited by 1,052
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
Ascorbate regulation and its neuroprotective role in the brain
Rice, M. E. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01543-x · Cited by 825 · cited 2×
“Te redox cycling of copper requires its reduction by biological components, including ascorbate, which is actively present in the brain at high concentrations [22].”
Emerging roles of oxidative stress in brain aging and Alzheimer's disease
Ionescu-Tucker, A., & Cotman, C. W. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.07.014 · Cited by 737
Robinson, N. J., & Winge, D. R. (2010) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030409-143539 · Cited by 708
Metals in Alzheimer's and Parkinson's Diseases
Barnham, K. J., & Bush, A. I. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.02.019 · Cited by 695 · cited 1×
“Among the main and consistent features of AD, oxidative stress and imbalances in the metal ions homeostasis have a critical role [10, 11].”
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672 · cited 3×
“Clinically, AD is characterized by a progressive loss of memory, a degeneration of cognitive skills [7, 8], and a loss of neurons that occurs in the cerebral cortex and hippocampus of the brain [9].”
Curtain, C. C., Ali, F., Volitakis, I., Cherny, R. A., Norton, R. S., Beyreuther, K., Barrow, C. J., Masters, C. L., Bush, A. I., & Barnham, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100175200 · Cited by 649 · cited 1×
“A β plays a key role in the metal ion–mediated ROS production during oxidative stress [24, 74–76].”
Metalloenzyme-like Activity of Alzheimer's Disease β-Amyloid
Opazo, C., Huang, X., Cherny, R. A., Moir, R. D., Roher, A. E., White, A. R., Cappai, R., Masters, C. L., Tanzi, R. E., Inestrosa, N. C., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206428200 · Cited by 579
Biological metals and metal-targeting compounds in major neurodegenerative diseases
Barnham, K. J., & Bush, A. I. (2014) · Chem. Soc. Rev. · doi:10.1039/c4cs00138a · Cited by 497 · cited 1×
“Increasing evidence suggests that the neuronal cell lost in AD is linked, at least partially, to an excessive free radical generation [23], and the noncontrolled redox-active metal ions, especially copper, in the brain of patients with AD should be considered at the root of a cascade of events…”
Metal dyshomeostasis and oxidative stress in Alzheimer’s disease
Greenough, M. A., Camakaris, J., & Bush, A. I. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 436 · cited 1×
“A β plays a key role in the metal ion–mediated ROS production during oxidative stress [24, 74–76].”
β-Amyloid Monomers Are Neuroprotective
Giuffrida, M. L., Caraci, F., Pignataro, B., Cataldo, S., De Bona, P., Bruno, V., Molinaro, G., Pappalardo, G., Messina, A., Palmigiano, A., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1736-09.2009 · Cited by 421 · cited 1×
“Tese results are consistent with the observation that a β monomer is nontoxic to cells as reported in the literature [94, 95].”
The chemistry of Alzheimer’s disease
Rauk, A. (2009) · Chemical Society Reviews · doi:10.1039/b807980n · Cited by 417
Untangling Amyloid-β, Tau, and Metals in Alzheimer’s Disease
Savelieff, M. G., Lee, S., Liu, Y., & Lim, M. H. (2013) · ACS Chemical Biology · doi:10.1021/cb400080f · Cited by 400 · cited 1×
“Several studies have shown that the AD-afected brain contains elevated concentrations of transition metals accumulated in amyloid plaques, mainly copper, zinc, and iron, suggesting that these metal ions actively take part in the etiology of the pathology by interacting with a β peptide [3, 9, 12].”
The Metal Theory of Alzheimer's Disease
Bush, A. I. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129011 · Cited by 305
Djordjević, V. B. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)37002-6 · Cited by 293 · cited 1×
“Free radicals are generally acknowledged as serious threat for the correct cell functioning [90, 91].”
Multiple cognitive deficits during the transition to Alzheimer's disease
Bäckman, L., Jones, S., Berger, A. ‐., Laukka, E. J., & Small, B. J. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01386.x · Cited by 291
Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease
Eskici, G., & Axelsen, P. H. (2012) · Biochemistry · doi:10.1021/bi3006169 · Cited by 290
Faller, P. (2009) · ChemBioChem · doi:10.1002/cbic.200900321 · Cited by 285
Guilloreau, L., Combalbert, S., Sournia‐Saquet, A., Mazarguil, H., & Faller, P. (2007) · ChemBioChem · doi:10.1002/cbic.200700111 · Cited by 270
Hureau, C., & Faller, P. (2009) · Biochimie · doi:10.1016/j.biochi.2009.03.013 · Cited by 259
Tabner, B. J., El-Agnaf, O. M. A., Turnbull, S., German, M. J., Paleologou, K. E., Hayashi, Y., Cooper, L. J., Fullwood, N. J., & Allsop, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500238200 · Cited by 242 · cited 1×
“In vitro studies have shown that, in the presence of copper, a β can produce H 2 O 2 by reducing molecular oxygen [38–40] and catalyzing ascorbate oxidation with the generation of hydroxyl radical ( • OH) through Fenton reaction [41–44].”
Tõugu, V., Tiiman, A., & Palumaa, P. (2011) · Metallomics · doi:10.1039/c0mt00073f · Cited by 225 · cited 1×
“Tese include (i) the aggregation of a β peptides to form senile plaques and neurofbrillary tangles [14–16] and/or (ii) the increase of metal ion-–mediated oxidative stress [9, 17].”
Kowalik-Jankowska, T., Ruta, M., Wiśniewska, K., & Łankiewicz, L. (2003) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(03)00128-4 · Cited by 222 · cited 1×
“…diference in ascorbate consumption and generation of HO • for a β 1–16 , a β 1–28 (a β fragments which are known to form complexes with Cu(II) [83–85]) and a β 1–40 (Figure S2), and thus the decrease in the efciency of the Fenton–Haber–Weiss reaction is due, as expected, only to the a β :Cu(II)…”
Metal Chelation as a Potential Therapy for Alzheimer's Disease
CUAJUNGCO, M. P., FAGÉT, K. Y., HUANG, X., TANZI, R. E., & BUSH, A. I. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06938.x · Cited by 215 · cited 1×
“Te rate of ascorbate consumption, as one of the re-actants of the Fenton–Haber–Weiss reaction, can provide an indirect index of the Cu(II) species’ ability to generate ROS 2 Bioinorganic Chemistry and Applications [48].”
Metals ions and neurodegeneration
Molina-Holgado, F., Hider, R. C., Gaeta, A., Williams, R., & Francis, P. (2007) · BioMetals · doi:10.1007/s10534-006-9033-z · Cited by 207 · cited 1×
“Among the main and consistent features of AD, oxidative stress and imbalances in the metal ions homeostasis have a critical role [10, 11].”
Brewer, G. J., Askari, F., Dick, R. B., Sitterly, J., Fink, J. K., Carlson, M., Kluin, K. J., & Lorincz, M. T. (2009) · Translational Research · doi:10.1016/j.trsl.2009.05.002 · Cited by 190 · cited 1×
“Copper metabolism is closely regulated and this ion is normally bound to proteins [18, 19], but the so-called Cu pool loosely bound can catalyze the production of reactive oxygen species (ROS) [20].”
Shearer, J., & Szalai, V. A. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805940m · Cited by 189 · cited 1×
“Te resulting Cu(I) cannot form complex with Semax but could form complex with a β , which is known to form relatively weak complex with Cu(I) [86–88].”
Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J., Greenough, M. A., Volitakis, I., Adlard, P. A., Cherny, R. A., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07402.x · Cited by 181 · cited 1×
“For this purpose, copper ion chelators have been widely studied and proposed as a potential strategy for AD therapy to attenuate abnormal metal-protein interactions that lead to increased free radical toxicity [47–53].”
Kanti Das, T., Wati, M. R., & Fatima-Shad, K. (2014) · Archives of Neuroscience · doi:10.5812/archneurosci.20078 · Cited by 177 · cited 1×
“Cu(II) and Cu(II) complexes (including a β complexes) are known to catalyze the production of ROS in the presence of oxygen and ascorbate [44, 79–81] through a Fenton–Haber–Weiss reaction [78].”
Alzheimer’s disease: How metal ions define β-amyloid function
Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 167
Hureau, C., & Dorlet, P. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.034 · Cited by 160
Himes, R. A., Park, G. Y., Siluvai, G. S., Blackburn, N. J., & Karlin, K. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200803908 · Cited by 149
Cassagnes, L., Hervé, V., Nepveu, F., Hureau, C., Faller, P., & Collin, F. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201305372 · Cited by 141
Cheignon, C., Jones, M., Atrián-Blasco, E., Kieffer, I., Faller, P., Collin, F., & Hureau, C. (2017) · Chemical Science · doi:10.1039/c7sc00809k · Cited by 132
Balland, V., Hureau, C., & Savéant, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011315107 · Cited by 131
Werner coordination chemistry and neurodegeneration
Telpoukhovskaia, M. A., & Orvig, C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35236b · Cited by 125
Nadal, R. C., Rigby, S. E. J., & Viles, J. H. (2008) · Biochemistry · doi:10.1021/bi8011093 · Cited by 122
Faller, P., & Hureau, C. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202697 · Cited by 118
Dikalov, S., Vitek, M. P., & Mason, R. P. (2003) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.004 · Cited by 110
Copper chaperones. The concept of conformational control in the metabolism of copper
Palumaa, P. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.05.019 · Cited by 108 · cited 1×
“Copper metabolism is closely regulated and this ion is normally bound to proteins [18, 19], but the so-called Cu pool loosely bound can catalyze the production of reactive oxygen species (ROS) [20].”
Aliès, B., Badei, B., Faller, P., & Hureau, C. (2011) · Chemistry - A European Journal · doi:10.1002/chem.201102746 · Cited by 106 · cited 2×
“Te result is consistent with the higher Semax afnity for copper with respect to a β by several orders of magnitude [71, 86].”
Jiang, D., Li, X., Liu, L., Yagnik, G. B., & Zhou, F. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp9095375 · Cited by 83
Cheignon, C., Faller, P., Testemale, D., Hureau, C., & Collin, F. (2016) · Metallomics · doi:10.1039/c6mt00150e · Cited by 81 · cited 2×
“In vitro studies have shown that, in the presence of copper, a β can produce H 2 O 2 by reducing molecular oxygen [38–40] and catalyzing ascorbate oxidation with the generation of hydroxyl radical ( • OH) through Fenton reaction [41–44].”
Amyloid-β Metal Interaction and Metal Chelation
Cuajungco, M. P., Frederickson, C. J., & Bush, A. I. (2006) · Springer eBooks · doi:10.1007/0-387-23226-5_12 · Cited by 71 · cited 1×
“For this purpose, copper ion chelators have been widely studied and proposed as a potential strategy for AD therapy to attenuate abnormal metal-protein interactions that lead to increased free radical toxicity [47–53].”
Dynamic action of neurometals at the synapse
Tamano, H., & Takeda, A. (2011) · Metallomics · doi:10.1039/c1mt00008j · Cited by 70 · cited 1×
“Tese essential transition metal ions have important functions in the brain [13] and maintaining their homeostasis is critical for the brain functions.”
Korshavn, K. J., Jang, M., Kwak, Y. J., Kochi, A., Vertuani, S., Bhunia, A., Manfredini, S., Ramamoorthy, A., & Lim, M. H. (2015) · Scientific Reports · doi:10.1038/srep17842 · Cited by 68
Capturing a Reactive State of Amyloid Aggregates
Parthasarathy, S., Yoo, B., McElheny, D., Tay, W. M., & Ishii, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511345 · Cited by 62
Atrián-Blasco, E., del Barrio, M., Faller, P., & Hureau, C. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00740 · Cited by 62 · cited 2×
“Tis behavior is in agreement with literature data which report a moderate ROS generation of a β :Cu(II) complex compared to “free” copper, due to a more difcult redox-cycling [35, 79].”
Dmitrieva, V. G., Povarova, O. V., Skvortsova, V. I., Limborska, S. A., Myasoedov, N. F., & Dergunova, L. V. (2010) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9432-0 · Cited by 54 · cited 2×
“…models [73] and our fndings on Semax’s signifcant reduction of ROS production by the a β -Cu(II) complex, along with its known roles in various biological processes [61, 63–66], Semax could be considered a potential adjuvant in therapeutic approaches for neurodegenerative diseases such as AD.”
Cu(II) enhances the effect of Alzheimer’s amyloid-β peptide on microglial activation
Yu, F., Gong, P., Hu, Z., Qiu, Y. L., Cui, Y., Gao, X., Chen, H., & Li, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0343-3 · Cited by 52 · cited 1×
“Interestingly, recent evidence showed that Cu(II) enhances the efect of a β on microglial activation and neurotoxicity involving mitochondrial ROS production [45] and potentiates the spatial memory defcit induced by a β in the hippocampus of rats [46].”
Giuffrida, M. L., Tomasello, M. F., Pandini, G., Caraci, F., Battaglia, G., Busceti, C., Di Pietro, P., Pappalardo, G., Attanasio, F., Chiechio, S., et al. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00297 · Cited by 52 · cited 1×
“Tese results are consistent with the observation that a β monomer is nontoxic to cells as reported in the literature [94, 95].”
Self-citationBehzadfar, L., Abdollahi, M. R., Sabzevari, O., Hosseini, R., Salimi, A., Naserzadeh, P., Sharifzadeh, M. S., & Pourahmad, J. (2017) · Metallomics · doi:10.1039/c7mt00075h · Cited by 52 · cited 1×
“Interestingly, recent evidence showed that Cu(II) enhances the efect of a β on microglial activation and neurotoxicity involving mitochondrial ROS production [45] and potentiates the spatial memory defcit induced by a β in the hippocampus of rats [46].”
Yako, N., Young, T. R., Cottam, J. M., Hutton, C. A., Wedd, A. G., & Xiao, Z. (2017) · Metallomics · doi:10.1039/c6mt00299d · Cited by 46 · cited 1×
“…diference in ascorbate consumption and generation of HO • for a β 1–16 , a β 1–28 (a β fragments which are known to form complexes with Cu(II) [83–85]) and a β 1–40 (Figure S2), and thus the decrease in the efciency of the Fenton–Haber–Weiss reaction is due, as expected, only to the a β…”
Oxidative Stress and Amyloid Toxicity: Insights From Yeast
França, M. B., Lima, K., & Eleuthério, E. C. A. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25803 · Cited by 45 · cited 1×
“Notably, oxidative stress signifcantly contributes to the development of a β toxicity [92, 93].”
Impact of N‐Truncated Aβ Peptides on Cu‐ and Cu(Aβ)‐Generated ROS: CuI Matters!
Esmieu, C., Ferrand, G., Borghesani, V., & Hureau, C. (2021) · Chemistry – A European Journal · doi:10.1002/chem.202003949 · Cited by 43
Redox processes in Cu-binding proteins: the “in-between” states in intrinsically disordered peptides
Falcone, E., & Hureau, C. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00443k · Cited by 43 · cited 1×
“Indeed, the binding of a β to redox active metals (i.e., Cu) can facilitate redox cycling leading to the production of ROS and increasing the oxidative stress [30–37].”
Atrián-Blasco, E., Cerrada, E., Conte-Daban, A., Testemale, D., Faller, P., Laguna, M., & Hureau, C. (2015) · Metallomics · doi:10.1039/c5mt00077g · Cited by 42 · cited 1×
“Indeed, after 30 min, we observed the total ascorbate consumption (Figure 1(a), red curve) and the conversion of 3-CCA into the fuorescent species 7-OH-CCA (Figure 1(b), red curve) [43, 78, 82].”
Furlan, S., Hureau, C., Faller, P., & Penna, G. L. (2012) · The Journal of Physical Chemistry B · doi:10.1021/jp308977s · Cited by 41
Cheignon, C., Collin, F., Faller, P., & Hureau, C. (2016) · Dalton Transactions · doi:10.1039/c6dt01979j · Cited by 39 · cited 4×
“Moreover, the results are in agreement with the observation that a β scavenges the HO • due to its proximity to the site of ROS production and is oxidized regardless of ascorbate concentrations [78].”
InfluentialNoël, S., Perez, F., Pedersen, J. T., Aliès, B., Mallet‐Ladeira, S., Sayen, S., Guillon, E., Gras, E., & Hureau, C. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.05.016 · Cited by 37
Bashkatova, V. G., Koshelev, V. B., Fadyukova, O. E., Alexeev, A. A., Vanin, A. F., Rayevsky, K. S., Ashmarin, I. P., & Armstrong, D. M. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03324-2 · Cited by 36 · cited 2×
“…models [73] and our fndings on Semax’s signifcant reduction of ROS production by the a β -Cu(II) complex, along with its known roles in various biological processes [61, 63–66], Semax could be considered a potential adjuvant in therapeutic approaches for neurodegenerative diseases such as AD.”
Zhang, W., Liu, Y., Hureau, C., Robert, A., & Meunier, B. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201801387 · Cited by 36
Medvedeva, E. V., Dmitrieva, V. G., Povarova, O. V., Limborska, S. A., Skvortsova, V. I., Myasoedov, N. F., & Dergunova, L. V. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-228 · Cited by 33 · cited 1×
“A large-scale study of the action mechanism at the transcriptome level was of particular interest [65, 67–70].”
A New Generation of Drugs: Synthetic Peptides Based on Natural Regulatory Peptides
Kolomin, T., Shadrina, M., Slominsky, P., Limborska, S., & Myasoedov, N. (2013) · Neuroscience and Medicine · doi:10.4236/nm.2013.44035 · Cited by 30 · cited 2×
“…models [73] and our fndings on Semax’s signifcant reduction of ROS production by the a β -Cu(II) complex, along with its known roles in various biological processes [61, 63–66], Semax could be considered a potential adjuvant in therapeutic approaches for neurodegenerative diseases such as AD.”
Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Sudarkina, O. Y., Dmitrieva, V. G., Gubsky, L. V., Myasoedov, N. F., Limborska, S. A., et al. (2020) · Genes · doi:10.3390/genes11060681 · Cited by 29 · cited 1×
“A large-scale study of the action mechanism at the transcriptome level was of particular interest [65, 67–70].”
[A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].
Ip, A., Nezavibat'ko, V. N., Nf, M., et al. (1997) · PubMed · Cited by 28
Semax as a Universal Drug for Therapy and Research
Koroleva, S. V., & Myasoedov, N. F. (2018) · Biology Bulletin · doi:10.1134/s1062359018060055 · Cited by 27 · cited 1×
“Indeed, it has been shown that the addition of the sequence enriched in proline residues to the C-terminus of ACTH(4–7) results in an increased duration of the behavioral efects of the peptide [60–62].”
del Barrio, M., Borghesani, V., Hureau, C., & Faller, P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804562-6.00014-2 · Cited by 26 · cited 1×
“In order to elucidate copper-mediated events in AD pathogenesis, the redox activity and the coordination chemistry of Cu(II)-a β have been the focus of several studies [25–30].”
Anwar, M. A., Iqbal, M., Qamar, M. A., et al. (2000) · World Journal of Microbiology and Biotechnology · doi:10.1023/a:1008978501177 · Cited by 25 · cited 1×
“Taking into consideration the molar extinction co-efcient value of 6.6 × 10 3 mol − 1 · cm − 1 [89] and the abs value (0.105) at L max , we found, from Lambert–Beer law, a concentration value for the copper(I) (BCA) 2 complex equivalent to the value of Cu(II) added (16 µ M).”
InfluentialMass Spectral Studies Reveal the Structure of Aβ1–16–Cu2+ Complex Resembling ATCUN Motif
Ginotra, Y. P., Ramteke, S., Srikanth, R., & Kulkarni, P. P. (2012) · Inorganic Chemistry · doi:10.1021/ic301244x · Cited by 23
Copper(ii) and zinc(ii) dependent effects on Aβ42 aggregation: a CD, Th-T and SFM study
Attanasio, F., Bona, P. D., Cataldo, S., Sciacca, M. F. M., Milardi, D., Pignataro, B., & Pappalardo, G. (2013) · New Journal of Chemistry · doi:10.1039/c3nj40999f · Cited by 21
Self-citationНиколаевна, Н. И., Grasso, G. I., Satriano, C., Travaglia, A., Mendola, D. L., Arena, G., & Rizzarelli, E. (2019) · Metallomics · doi:10.1039/c9mt00045c · Cited by 21 · cited 1×
“Following 24 h of treatments, SH-SY5Y cell viability was estimated by using the MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) as described previously [100].”
Sciacca, M. F. M., Николаевна, Н. И., Giuffrida, M. L., & Attanasio, F. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00707 · Cited by 20
Self-citationFalcone, E., & Faller, P. (2023) · Dalton Transactions · doi:10.1039/d2dt03875g · Cited by 20
Neurotrophin gene expression in rat brain under the action of Semax, an analogue of ACTH4–10
Agapova, T. Y., Agniullin, Y. V., Shadrina, M. I., Shram, S. I., Slominsky, P. A., Lymborska, S. A., & Myasoedov, N. F. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.02.042 · Cited by 18 · cited 1×
“A large-scale study of the action mechanism at the transcriptome level was of particular interest [65, 67–70].”
Tabbì, G., Magrì, A., Giuffrida, A., Lanza, V., Pappalardo, G., Naletova, I., Nicoletti, V. G., Attanasio, F., & Rizzarelli, E. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.09.008 · Cited by 18 · cited 6×
“…M at pH � 7.4) [71] with respect to Zn(II) ions (K D 1.8 × 10 − 5 M at pH � 7.4) [72] and a protective ability against metal-induced cell toxicity [71]; (ii) acetylation of the N-terminal amino group afects copper(II) and zinc(II) chelation properties of Semax and the inhibition of the…”
InfluentialSelf-citationZolotarev, Y. A., Dolotov, O. V., Inozemtseva, L. S., Dadayan, A. K., Dorokhova, E. M., Андреева, Л. А., Alfeeva, L. Y., Grivennikov, I. A., & Myasoedov, N. F. (2006) · Amino Acids · doi:10.1007/s00726-006-0328-8 · Cited by 15 · cited 1×
“Indeed, it has been shown that the addition of the sequence enriched in proline residues to the C-terminus of ACTH(4–7) results in an increased duration of the behavioral efects of the peptide [60–62].”
Unexpected Trends in Copper Removal from Aβ Peptide: When Less Ligand Is Better and Zn Helps
Esmieu, C., Balderrama-Martínez-Sotomayor, R., Conte‐Daban, A., Iranzo, O., & Hureau, C. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.0c03407 · Cited by 15
Sudarkina, O. Y., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Remizova, J. A., Dmitrieva, V. G., Gubsky, L. V., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126179 · Cited by 15
Gonzalez, P., Sabater, L., Mathieu, E., Faller, P., & Hureau, C. (2022) · Biomolecules · doi:10.3390/biom12101327 · Cited by 13 · cited 2×
“In particular, N4-tetradentate copper specifc ligands have been taken into consideration for their ability to strongly bind copper without interfering with zinc homeostasis, the most common metal ion involved in neuronal signal transduction [54–58].”
Evaluation of Copper Chelation Therapy in a Transgenic Rat Model of Cerebral Amyloid Angiopathy
Ambi, A., Stanisavljevic, A., Victor, T. W., Lowery, A. W., Davis, J., Nostrand, W. E. V., & Miller, L. M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00483 · Cited by 12
Rulmont, C., Stigliani, J., Hureau, C., & Esmieu, C. (2024) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c02693 · Cited by 12 · cited 1×
“In particular, N4-tetradentate copper specifc ligands have been taken into consideration for their ability to strongly bind copper without interfering with zinc homeostasis, the most common metal ion involved in neuronal signal transduction [54–58].”
Drommi, M., Rulmont, C., Esmieu, C., & Hureau, C. (2021) · Molecules · doi:10.3390/molecules26247630 · Cited by 11 · cited 1×
“Tese observations are in accord with the behavior previously reported for other ACTUN motifs by various authors [57, 96–98].”
Magrì, A., Tabbì, G., Giuffrida, A., Pappalardo, G., Satriano, C., Naletova, I., Nicoletti, V. G., & Attanasio, F. (2016) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2016.08.013 · Cited by 9
Self-citationZimmeter, K., Vileno, B., Platas‐Iglesias, C., Vinjamuri, B., Sour, A., & Faller, P. (2023) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c00480 · Cited by 9
Dergunova, L. V., Dmitrieva, V. G., Filippenkov, I. B., Stavchansky, V. V., Denisova, A. E., Yuzhakov, V. V., Sevan’kaeva, L. E., Valieva, L. V., Sudarkina, O. Y., Gubsky, L. V., et al. (2021) · Molecular Biology · doi:10.1134/s0026893321010040 · Cited by 8
Dergunova, L. V., Dmitrieva, V. G., Filippenkov, I. B., Ставчанский, В. В., Denisova, A. E., Южаков, В. В., Sevan’kaeva, L. E., Valieva, L. V., Sudarkina, O. Y., Губский, Л. В., et al. (2021) · Molecular Biology · doi:10.31857/s0026898421010043 · Cited by 7
Bock, R. (1962) · Angewandte Chemie · doi:10.1002/ange.19620740332 · Cited by 4
Zhang, W.-X., Liu, Y., Hureau, C., Robert, A., & Meunier, B. (2018) · Chemistry - A European Journal · doi:10.1002/chem.201883164
(1996) · doi:10.1002/(sici)1520-6769(199609)19:2<115::aid-nrc171>3.0.co;2-b
Cited by
Wang, X.-Q., Wang, Y., Ye, Z.-H., Zhang, Z., & Cen, S.-F. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1868164 · Cited by 2
Jiang, X., Zhang, H., Ping, S., et al. (2026) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2026.113214 · Cited by 1
Li, B., Qiu, J., & Bai, X. (2026) · ACS Omega · doi:10.1021/acsomega.5c10804
Metadata
- Authors
- Tomasello, M. F., Di Rosa, M. C., Naletova, I., Sciacca, M. F. M., Giuffrida, A., Maccarrone, G., & Attanasio, F.
- Affiliations
- National Research Council (IT)
- University of Catania (IT)
- Corresponding author
- Attanasio, Francesco
- ORCID
- Venue
- Bioinorganic Chemistry and Applications
- Publisher
- Wiley
- Published
- 2025-01
- Volume
- 2025
- Issue
- 1
- Pages
- 4226220-4226220
- ISSN
- 1565-3633 (ISSN-L)
- 1687-479X
- PMC
- PMC12151629
- OpenAlex
- W4410974228
- Semantic Scholar
- 1d332b6269d46d8a917bda24f181ebee14e42824
- Cited by
- 3
- References
- 102
- Citations by year
- 2026: 3
- FWCI
- 1.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor, 153 d)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Bioinorganic Chemistry and Applications (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Keywords
- Semax, Alzheimer's disease, amyloid-beta, Fenton-like reaction, reactive oxygen species, oxidative stress, SH-SY5Y cells, neuroprotection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.